MarketPeel
Insider Trading Intelligence
DV

Der Baan Bastiaan Jeroen Van

LIXT
PRESIDENT AND CEO · LIXTE BIOTECHNOLOGY HOLDINGS, INC. · CIK 0001938070
FILING MIX · LIFETIME100%/0%
BUYS
8
SELLS
0
TOTAL VALUE
$81.9K
COMPANIES
1
ACTIVE SINCE
Jun 2022
HOLDINGS NOW
11,000
AVG SELL PX
TRADE KIND
SHOWING 8 / 8
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Der Baan Bastiaan Jeroen Van, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+66.67%+3.33%+2.01%+1.32%+4.61%
14d3+66.67%+7.02%+3.94%+3.07%+7.78%
30d3+100.00%+33.23%+3.89%+29.34%+44.54%
60d3+66.67%+48.18%+5.38%+42.80%+74.67%
90d3+66.67%+35.42%+8.16%+27.25%+55.37%
180d3+100.00%+17.82%+18.23%-0.40%-3.38%
1y3+0.00%-46.23%+29.70%-75.93%-80.01%
2y3+33.33%-8.48%+59.41%-67.88%-118.86%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
LIXT · 11,000 shares · as of Oct 3, 2023
062,500125,000187,500250,0002023SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2022
2022
2022
2023
2023
2023
2023
FLOW · 8 buys / 0 sellsCOVERAGE · 7 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
PURCHASE
President and CEO
10,000$2.80$28.0K11,000Oct 3, 2023Oct 5, 2023View →
LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
PURCHASEGRANT
Stock grant
250,000250,000Sep 26, 2023Oct 16, 2023View →
LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
PURCHASEGRANT
Stock grant
250,000250,000Sep 26, 2023Sep 27, 2023View →
LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
PURCHASEGRANT
Stock grant
10,00010,000Jun 30, 2023Sep 27, 2023View →
LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
PURCHASE
10,000$4.90$49.0K10,000Dec 30, 2022Jan 3, 2023View →
LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
PURCHASE
10,000$0.49$4.9K10,000Dec 30, 2022Jan 4, 2023View →
LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
PURCHASEGRANT
Stock grant
25,00025,000Jun 17, 2022Sep 27, 2023View →
LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
PURCHASEGRANT
Stock grant
250,000250,000Jun 17, 2022Jun 23, 2022View →
Other insiders · LIXT
Loading peer insiders…
About this filer
CIK 0001938070
ROLE
President and CEO
PRIMARY
LIXT
COMPANIES
1
ACTIVE SINCE
Jun 2022
MARKETPEEL · /INSIDER/0001938070DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback